150 related articles for article (PubMed ID: 25349976)
21. Circulating insulin-like growth factor I in relation to melanoma risk in the European prospective investigation into cancer and nutrition.
Bradbury KE; Appleby PN; Tipper SJ; Travis RC; Allen NE; Kvaskoff M; Overvad K; Tjønneland A; Halkjaer J; Cervenka I; Mahamat-Saleh Y; Bonnet F; Kaaks R; Fortner RT; Boeing H; Trichopoulou A; La Vecchia C; Stratigos AJ; Palli D; Grioni S; Matullo G; Panico S; Tumino R; Peeters PH; Bueno-de-Mesquita HB; Ghiasvand R; Veierød MB; Weiderpass E; Bonet C; Molina E; Huerta JM; Larrañaga N; Barricarte A; Merino S; Isaksson K; Stocks T; Ljuslinder I; Hemmingsson O; Wareham N; Khaw KT; Gunter MJ; Rinaldi S; Tsilidis KK; Aune D; Riboli E; Key TJ
Int J Cancer; 2019 Mar; 144(5):957-966. PubMed ID: 30191956
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer.
Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
Tumour Biol; 2014 Apr; 35(4):3125-32. PubMed ID: 24254307
[TBL] [Abstract][Full Text] [Related]
23. Reduced expression and growth inhibitory activity of the aging suppressor klotho in epithelial ovarian cancer.
Lojkin I; Rubinek T; Orsulic S; Schwarzmann O; Karlan BY; Bose S; Wolf I
Cancer Lett; 2015 Jul; 362(2):149-57. PubMed ID: 25827069
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.
Ose J; Schock H; Tjønneland A; Hansen L; Overvad K; Dossus L; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopolou A; Benetou V; Lagiou P; Masala G; Tagliabue G; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Onland-Moret NC; Weiderpass E; Gram IT; Sánchez S; Obon-Santacana M; Sànchez-Pérez MJ; Larrañaga N; Castaño JM; Ardanaz E; Brändstedt J; Lundin E; Idahl A; Travis RC; Khaw KT; Rinaldi S; Romieu I; Merritt MA; Gunter MJ; Riboli E; Kaaks R; Fortner RT
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):951-61. PubMed ID: 25855626
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies.
Rinaldi S; Cleveland R; Norat T; Biessy C; Rohrmann S; Linseisen J; Boeing H; Pischon T; Panico S; Agnoli C; Palli D; Tumino R; Vineis P; Peeters PH; van Gils CH; Bueno-de-Mesquita BH; Vrieling A; Allen NE; Roddam A; Bingham S; Khaw KT; Manjer J; Borgquist S; Dumeaux V; Torhild Gram I; Lund E; Trichopoulou A; Makrygiannis G; Benetou V; Molina E; Donate Suárez I; Barricarte Gurrea A; Gonzalez CA; Tormo MJ; Altzibar JM; Olsen A; Tjonneland A; Grønbaek H; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Morois S; Slimani N; Boffetta P; Jenab M; Riboli E; Kaaks R
Int J Cancer; 2010 Apr; 126(7):1702-15. PubMed ID: 19810099
[TBL] [Abstract][Full Text] [Related]
26. Circulating IGF system and treatment outcome in epithelial ovarian cancer.
Huang YF; Cheng WF; Wu YP; Cheng YM; Hsu KF; Chou CY
Endocr Relat Cancer; 2014 Apr; 21(2):217-29. PubMed ID: 24273235
[TBL] [Abstract][Full Text] [Related]
27. Breastfeeding and ovarian cancer risk: a meta-analysis of epidemiologic studies.
Luan NN; Wu QJ; Gong TT; Vogtmann E; Wang YL; Lin B
Am J Clin Nutr; 2013 Oct; 98(4):1020-31. PubMed ID: 23966430
[TBL] [Abstract][Full Text] [Related]
28. Dietary fat intake and risk of epithelial ovarian cancer by tumour histology.
Merritt MA; Cramer DW; Missmer SA; Vitonis AF; Titus LJ; Terry KL
Br J Cancer; 2014 Mar; 110(5):1392-401. PubMed ID: 24473401
[TBL] [Abstract][Full Text] [Related]
29. Childhood body fatness and the risk of epithelial ovarian cancer: A population-based case-control study in Montreal, Canada.
L'Espérance K; Abrahamowicz M; O'Loughlin J; Koushik A
Prev Med; 2024 Jan; 178():107794. PubMed ID: 38072312
[TBL] [Abstract][Full Text] [Related]
30. Epithelial ovarian cancers and endometriosis.
Acién P; Velasco I; Acién M; Capello C; Vela P
Gynecol Obstet Invest; 2015; 79(2):126-35. PubMed ID: 25634648
[TBL] [Abstract][Full Text] [Related]
31. Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma.
Lessard-Anderson CR; Handlogten KS; Molitor RJ; Dowdy SC; Cliby WA; Weaver AL; Sauver JS; Bakkum-Gamez JN
Gynecol Oncol; 2014 Dec; 135(3):423-7. PubMed ID: 25316178
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of IGF1 by tumor-associated macrophages promotes the proliferation and migration of epithelial ovarian cancer cells.
Liu L; Wang X; Li X; Wu X; Tang M; Wang X
Oncol Rep; 2018 Feb; 39(2):818-826. PubMed ID: 29251331
[TBL] [Abstract][Full Text] [Related]
33. Prediagnostic circulating concentrations of plasma insulin-like growth factor-I and risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition.
Perez-Cornago A; Appleby PN; Tipper S; Key TJ; Allen NE; Nieters A; Vermeulen R; Roulland S; Casabonne D; Kaaks R; Fortner RT; Boeing H; Trichopoulou A; La Vecchia C; Klinaki E; Hansen L; Tjønneland A; Bonnet F; Fagherazzi G; Boutron-Ruault MC; Pala V; Masala G; Sacerdote C; Peeters PH; Bueno-de-Mesquita HB; Weiderpass E; Dorronsoro M; Quirós JR; Barricarte A; Gavrila D; Agudo A; Borgquist S; Rosendahl AH; Melin B; Wareham N; Khaw KT; Gunter M; Riboli E; Vineis P; Travis RC
Int J Cancer; 2017 Mar; 140(5):1111-1118. PubMed ID: 27870006
[TBL] [Abstract][Full Text] [Related]
34. Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case-control study.
Wilailak S; Vipupinyo C; Suraseranivong V; Chotivanich K; Kietpeerakool C; Tanapat Y; Therasakvichya S; Hamontri S; Linasmita V; Bunyapipat S; Chindavijak S; Ittiwisavakul K; Khemapech N; Suekwattana P; Thanapprapasr D; Lumbiganon P
BJOG; 2012 May; 119(6):672-7. PubMed ID: 22489761
[TBL] [Abstract][Full Text] [Related]
35. Epithelial ovarian cancer and recreational physical activity: A review of the epidemiological literature and implications for exercise prescription.
Cannioto RA; Moysich KB
Gynecol Oncol; 2015 Jun; 137(3):559-73. PubMed ID: 25797080
[TBL] [Abstract][Full Text] [Related]
36. Social support and ovarian cancer incidence - A Swedish prospective population-based study.
Idahl A; Hermansson A; Lalos A
Gynecol Oncol; 2018 May; 149(2):324-328. PubMed ID: 29555331
[TBL] [Abstract][Full Text] [Related]
37. Molecular signatures of epithelial ovarian cancer: analysis of associations with tumor characteristics and epidemiologic risk factors.
Schildkraut JM; Iversen ES; Akushevich L; Whitaker R; Bentley RC; Berchuck A; Marks JR
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1709-21. PubMed ID: 23917454
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer.
Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL
Oncotarget; 2015 Sep; 6(29):28491-501. PubMed ID: 26143638
[TBL] [Abstract][Full Text] [Related]
39. Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study.
Drogan D; Schulze MB; Boeing H; Pischon T
Am J Epidemiol; 2016 Mar; 183(6):553-60. PubMed ID: 26880678
[TBL] [Abstract][Full Text] [Related]
40. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
